STRO · Sutro Biopharma, Inc. · Documents
Market Cap
$254.36M
Shares
16.58M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 10-Q | 2026-08-12 | 2026-06-30 | |
| 8-K | 2026-08-12 | — | |
| 8-K | 2026-06-08 | 2026-06-05 | |
| Investor Event Transcript | 2026-06-04 | 2026-06-30 | |
| 10-Q | 2026-05-14 | 2026-03-31 | |
| 8-K | 2026-05-14 | — | |
| DEF 14A | 2026-04-22 | 2026-06-05 | |
| 10-K | 2026-03-23 | 2025-12-31 | |
| 8-K | 2026-03-23 | — | |
| 8-K | 2026-02-10 | 2026-02-09 | |
| 8-K | 2025-12-17 | — | |
| 8-K | 2025-12-03 | 2025-12-01 | |
| 8-K | 2025-11-06 | — | |
| 10-Q | 2025-11-06 | 2025-09-30 | |
| 8-K | 2025-09-29 | — | |
| 8-K | 2025-08-07 | — | |
| 10-Q | 2025-08-07 | 2025-06-30 | |
| 8-K | 2025-06-25 | 2025-06-20 | |
| 8-K | 2025-06-10 | 2025-06-06 | |
| 8-K | 2025-06-02 | — | |
| 8-K | 2025-05-08 | — | |
| 10-Q | 2025-05-08 | 2025-03-31 | |
| DEF 14A | 2025-04-25 | 2025-06-06 | |
| 8-K | 2025-04-14 | 2025-04-10 | |
| 10-K | 2025-03-13 | 2024-12-31 | |
| 8-K | 2025-03-13 | — | |
| 8-K | 2024-12-10 | — | |
| 8-K | 2024-11-13 | — | |
| 10-Q | 2024-11-13 | 2024-09-30 | |
| 8-K | 2024-08-13 | — | |
| 10-Q | 2024-08-13 | 2024-06-30 | |
| 8-K | 2024-08-12 | 2024-08-08 | |
| 8-K | 2024-06-10 | 2024-06-06 | |
| 10-Q | 2024-05-13 | 2024-03-31 | |
| 8-K | 2024-05-13 | — | |
| DEF 14A | 2024-04-26 | 2024-06-06 | |
| 8-K | 2024-04-02 | 2024-03-29 | |
| 8-K | 2024-04-02 | — | |
| 8-K | 2024-03-25 | — | |
| 10-K | 2024-03-25 | 2023-12-31 | |
| 8-K | 2024-02-09 | — | |
| 8-K | 2024-01-08 | 2024-01-04 | |
| 8-K | 2023-11-27 | 2023-11-21 | |
| 8-K | 2023-11-21 | — | |
| 10-Q | 2023-11-13 | 2023-09-30 | |
| 8-K | 2023-11-13 | — | |
| 8-K | 2023-10-04 | 2023-09-28 | |
| 8-K | 2023-08-10 | — | |
| 10-Q | 2023-08-10 | 2023-06-30 | |
| 8-K | 2023-06-26 | 2023-06-21 |
Showing 1–50 of 117 filings